Layer 1

Allergan recalls eye ointment over particle fears

MHRA: Recalling affected batches is likely to result in shortages

The manufacturer of Lacri-Lube is concerned particles around the nozzle of the tube could get into patients' eyes, says the MHRA

Allergan Limited has recalled two batches of its Lacri-Lube eye ointment after receiving a "small number of complaints" about patients finding black particles around the nozzle of the tube, the UK medicines watchdog has announced.

The particles, which are produced when the caps of the 3.5g and 5g tubes are “overtightened” during the manufacturing process, could get into patients' eyes when the product is administered, the Medicines and Healthcare products Regulatory Authority (MHRA) warned yesterday (September 21).

Remaining stock of the two affected batches should be quarantined and returned to their original supplier, the watchdog said. It said unaffected stock should become available to pharmacists by "late November". 

This is “likely to result in a shortage of the product” and a normal supply is unlikely to resume until early next year, the MHRA stressed.

Pharmacists with stock enquiries should contact Allergan Customer Services on 0800 3767975 and choose option 2, or email [email protected]. Those with medical enquiries should contact 01628 494026 or email [email protected], the MHRA added.

The affected batches are:

Batch Number

Expiry date

Pack size

Date of first distribution

84663

Apr-2017

5g

11.06.2014

84709

Apr-2017

5g

03.07.2014

84822

Apr-2017

5g

03.07.2014

84910

May-2017

5g

29.07.2014

84921

May-2017

5g

31.07.2014

84988

May-2017

5g

13.08.2014

85052

May-2017

5g

15.08.2014

85086

May-2017

5g

28.08.2014

86067

Aug-2017

5g

11.12.2014

86066

Aug-2017

5g

22.12.2014

86075

Aug-2017

5g

12.01.2015

86124

Aug-2017

5g

12.01.2015

86288

Sep-2017

5g

02.02.2015

86400

Sep-2017

5g

13.02.2015

86455

Sep-2017

5g

20.02.2015

86668

Oct-2017

5g

25.02.2015

86669

Oct-2017

5g

25.02.2015

86673

Oct-2017

5g

10.03.2015

86722

Oct-2017

5g

25.03.2015

86857

Oct-2017

5g

23.02.2015

86872

Oct-2017

5g

09.04.2015

86893

Nov-2017

5g

13.04.2015

86901

Nov-2017

5g

22.04.2015

86935

Nov-2017

5g

01.05.2015

85276

Jun-2017

5g

28.08.2014

85413

Jun-2017

5g

08.10.2014

85595

Jul-2017

5g

22.10.2014

85612

Jul-2017

5g

04.11.2014

85705

Jul-2017

5g

25.11.2014

85889

Aug-2017

5g

02.12.2014

85969

Aug-2017

5g

03.12.2014

84830

Apr-2017

3.5g

06.10.2014

84930

May-2017

3.5g

17.10.2014

85346

Jun-2017

3.5g

03.11.2014

85428

Jun-2017

3.5g

18.11.2014

85579

Jul-2017

3.5g

01.12.2014

85621

Jul-2017

3.5g

17.12.2014

85706

Jul-2017

3.5g

29.12.2014

85883

Aug-2017

3.5g

13.01.2015

85958

Aug-2017

3.5g

27.01.2015

85971

Aug-2017

3.5g

25.02.2015

86487

Sep-2017

3.5g

10.03.2015

86598

Oct-2017

3.5g

23.03.2015

86677

Oct-2017

3.5g

08.04.2015

86729

Oct-2017

3.5g

20.04.2015

87160

Dec-2017

3.5g

06.05.2015

87256

Dec-2017

3.5g

08.04.2015

87491

Jan-2018

3.5g

10.07.2015

87803

Feb-2018

3.5g

03.06.2015

88541

Apr-2018

3.5g

09.07.2015

 


Do you have an affected batch?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

2 Comments

Z ZZzzzz, Information Technology

What I want to know is why it has taken almost 4 weeks for this recall to happen in the UK when the same recall has already happened in the US. Typical of multinationals treating the UK as 2nd class citizens.

Andrew Platten, Other pharmacist

.

Job of the week

Pharmacist / Manager
Doncaster, South Yorkshire
To be negotiated + benefits